| Literature DB >> 16596144 |
Olivier Rouvière1, Raymonde Bouvier, Sylvie Négrier, Lionel Badet, Denis Lyonnet.
Abstract
Defining rational follow-up guidelines in patients treated for cancer is important, from both a medical and an economical perspective. Renal-cell carcinoma is reputed to be unpredictable in its course and only a few, and often contradictory, follow-up guidelines exist for patients treated for nonmetastatic renal-cell carcinoma. Recent advances in tumor biology have contributed to a better understanding of this cancer and have indicated that personalized follow-up regimens, based on tumor and host molecular characteristics, might be possible in the near future.Entities:
Mesh：
Substances：
Year: 2006 PMID： 16596144 DOI： 10.1038/ncponc0479
Source DB: PubMed Journal: Nat Clin Pract Oncol ISSN： 1743-4254